欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂:The Hippo–YAP pathway: new connections between regulation o

发布时间:2025-07-01

The Hippo–YAP pathway: new connections between regulation of organ size and cancer

Bin Zhao1, 2, Qun-Ying Lei3,  and Kun-Liang Guan1,

1Department of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093-0815, USA
2Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109, USA
3Department of Biological Chemistry, School of Medicine, and Molecular and Cellular Biology Laboratory, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China

The control of organ size is a basic biological question. In the past several years, the Hippo signaling pathway has been delineated and shown to be crucial in control of organ size in both Drosophila and mammals. Acting downstream of the Hippo pathway is the Yki/YAP/TAZ transcription co-activators. In mammalian cells, the Hippo pathway kinase cascade inhibits YAP and its paralog TAZ by phosphorylation and promotion of their cytoplasmic localization. The TEAD family transcription factors have recently been identified as evolutionarily conserved key mediators of YAP biological functions. yap is a candidate oncogene, and several other components of the Hippo pathway are tumor suppressors. Dysregulation of the Hippo pathway contributes to the loss of contact inhibition observed in cancer cells. Therefore, the Hippo–YAP pathway connects the regulation of organ size and tumorigenesis.

 

 

上一篇:LG化学2019年前投2.6亿美元对大山乙烯装置扩能
下一篇:西亚试剂:戊腈
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4